EUVIMEDEUVIMED entdecken
Crossref

Reprogramming of human γδ T cells by expression of an anti-CD19 TCR fusion construct (εTRuC) to enhance tumor killing

Claudia Juraske, Sonia M Krissmer, Evelyn S Teuber, Maria A Parigiani, Juliane Strietz, Daniela Wesch iD, Dieter Kabelitz, Susana Minguet, Wolfgang W Schamel iD

Journal of Leukocyte Biology · 2024

DOI: 10.1093/jleuko/qiad128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2024. Verfasst von Claudia Juraske und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Biological Signalling Studies BIOSS, Faculty of Biology, University of Freiburg, Schänzlestraße 18, 79104 Freiburg, Germany. Hauptthemen laut MEDLINE: Adenocarcinoma, Colonic Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We have developed a new format of a chimeric antigen receptor for αβ T cells, in which the single-chain variable fragment recognizing the tumor antigen is directly fused to the T cell receptor, called T cell receptor fusion construct (TRuC). Here, we express an anti-CD19 εTRuC in primary γδ T cells that were expanded using zoledronate (Zol) or concanavalin A. We show that the resulting εTRuC γδ T cells were reprogrammed to better recognize CD19-positive B cell tumors and—in case of the Zol-expanded cells—a CD19-expressing colon adenocarcinoma-derived cell line in vitro. This resulted in enhanced tumor killing, upregulation of the activation marker CD25, and secretion of cytokines. We found that the transduction efficiency of the concanavalin A–expanded cells was better than the one of the Zol-expanded ones. Our in vitro cytotoxicity data suggest that the Vδ2 T cells were better killers than the Vδ1 T cells. Finally, addition of vitamin C promoted the recovery of larger γδ T cell numbers after lentiviral transduction, as used for the expression of the εTRuC. In conclusion, the generation and use of γδ εTRuC T cells might be a new approach for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaColonic NeoplasmsHumansReceptors, Antigen, T-Cell, gamma-deltaConcanavalin AZoledronic AcidAntigens, CD19

Stichwörter der Autor:innen

CART cell receptorT cellsTRuCimmunotherapytumor

Substanzen

Receptors, Antigen, T-Cell, gamma-deltaConcanavalin AZoledronic AcidAntigens, CD19

Autor:innen und Institutionen

  • Centre for Biological Signalling Studies BIOSS, Faculty of Biology, University of Freiburg, Schänzlestraße 18, 79104 Freiburg, Germany.
  • Centre for Integrative Biological Signalling Studies CIBSS, Faculty of Biology, University of Freiburg, Schänzlestraße 18, 79104 Freiburg, Germany.
  • Centre for Chronic Immunodeficiency CCI, Medical Centre Freiburg, Faculty of Medicine, University of Freiburg, Breisacher Str. 115, 79106 Freiburg, Germany.
  • Spemann Graduate School of Biology and Medicine SGBM, University of Freiburg, Albertstraße 19A, 79104 Freiburg, Germany.
  • Institute of Immunology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Straße 3, 24105 Kiel, Germany.

ORCID-Profile: Daniela Wesch, Wolfgang W Schamel

Förderung

  • German Research Foundation

Zitieren

APA

Juraske, C., Krissmer, S. M., Teuber, E. S., Parigiani, M. A., Strietz, J., Wesch, D., Kabelitz, D., Minguet, S., & Schamel, W. W. (2024). Reprogramming of human γδ T cells by expression of an anti-CD19 TCR fusion construct (εTRuC) to enhance tumor killing. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiad128

Vancouver

Juraske C, Krissmer SM, Teuber ES, Parigiani MA, Strietz J, Wesch D, et al. Reprogramming of human γδ T cells by expression of an anti-CD19 TCR fusion construct (εTRuC) to enhance tumor killing. Journal of Leukocyte Biology. 2024. doi:10.1093/jleuko/qiad128

BibTeX
@article{Juraske2024,
  author = {Juraske, Claudia and Krissmer, Sonia M and Teuber, Evelyn S and Parigiani, Maria A and Strietz, Juliane and Wesch, Daniela and Kabelitz, Dieter and Minguet, Susana and Schamel, Wolfgang W},
  title = {Reprogramming of human γδ T cells by expression of an anti-CD19 TCR fusion construct (εTRuC) to enhance tumor killing},
  journal = {Journal of Leukocyte Biology},
  year = {2024},
  doi = {10.1093/jleuko/qiad128}
}
Kostenlos starten →